Evercore ISI Group Maintains Outperform on Boston Scientific, Raises Price Target to $81
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an Outperform rating on Boston Scientific (NYSE:BSX) and raised the price target from $78 to $81.
July 02, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evercore ISI Group has maintained an Outperform rating on Boston Scientific and raised the price target from $78 to $81, indicating confidence in the company's future performance.
The raised price target and maintained Outperform rating from a reputable analyst firm like Evercore ISI Group suggests positive sentiment and confidence in Boston Scientific's future performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100